Cáncer gástrico: factor de crecimiento epidérmico y receptor del factor de crecimiento epidérmico.

Translated title of the contribution: Gastric cancer: epidermal growth factor and epidermal growth factor receptor

Ivan Roa, J. C. Araya, Xabier de Aretxabala, I. Wistuba, M. Villaseca, K. Saito, K. Nakamura

    Research output: Contribution to journalArticlepeer-review

    1 Scopus citations

    Abstract

    In 19 patients with advanced gastric cancer the expression of epidermal growth factor receptor and epidermal growth factor (EGF) were studied using immunohistochemical techniques. There were 12 males and the mean age of the group was 54.8 years. Most cases belonged in Borrmann's types III or IV. Tumoral cells were positive for EGF receptor in 9 patients (47%), with a strong reaction in 6. Thirteen of 18 subjects were positive for EGF. The reaction for EGF receptor was positive in 20% of 12 patients with intestinal type tumors and in 67% of 7 patients with diffuse tumors. Reaction for EGF was positive in 80% of intestinal type tumors and 64% of diffuse tumors. Simultaneous positive reactions for both antigens was observed in 5 of 18 patients, all with diffuse type tumors. Signet ring cell tumors showed less positivity than less differentiated ones. Thus, the expression of EGF and EGF receptor was higher in our patients with advanced gastric cancer than reported elsewhere.

    Translated title of the contributionGastric cancer: epidermal growth factor and epidermal growth factor receptor
    Original languageSpanish
    Pages (from-to)5-12
    Number of pages8
    JournalRevista médica de Chile
    Volume120
    Issue number1
    StatePublished - Jan 1992

    ASJC Scopus subject areas

    • General Medicine

    Fingerprint

    Dive into the research topics of 'Gastric cancer: epidermal growth factor and epidermal growth factor receptor'. Together they form a unique fingerprint.

    Cite this